$PBIO Dr. Alexander Lazarev, PBI's Chief Scientifi
Post# of 3568
(Total Views: 192)
Posted On: 08/20/2020 6:53:51 AM
$PBIO Dr. Alexander Lazarev, PBI's Chief Scientific Officer, said: "This long-anticipated patent is an exciting endorsement of our efforts to transform biological sample preparation. Our PCT sample preparation workflows have been adopted not only in biomarker discovery and cancer research, but they are now advancing into enormous opportunities in clinical applications. More recently, PCT is now opening major opportunities in the biopharmaceutical development and manufacturing markets, ranging from protein characterization and quality control to bioprocess development, protein refolding and formulations development. Single use MicroPestle consumables enable research in all of these markets, and this powerful new dimension to our patent protected portfolio should help us to secure and accelerate the growth of our business."
Mr. Richard T. Schumacher, President and CEO of PBI, added: "This is a critical patent award and important news for PBI. The PCT MicroPestle consumable is integral to our current and future PCT expansion plans. Scientists worldwide continue to generate strong data showing that they can generate the highest quality analytical results by using the PCT MicroPestle, especially in the preparation of precious biopsy samples for analysis of biomarkers to diagnose disease and guide treatment selections. With the PCT MP patent now in hand, we have materially strengthened our intellectual property platform. We believe the newly patented PCT MP consumable will help drive sales of PCT systems into many new customer sites and applications globally."
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=270569
Mr. Richard T. Schumacher, President and CEO of PBI, added: "This is a critical patent award and important news for PBI. The PCT MicroPestle consumable is integral to our current and future PCT expansion plans. Scientists worldwide continue to generate strong data showing that they can generate the highest quality analytical results by using the PCT MicroPestle, especially in the preparation of precious biopsy samples for analysis of biomarkers to diagnose disease and guide treatment selections. With the PCT MP patent now in hand, we have materially strengthened our intellectual property platform. We believe the newly patented PCT MP consumable will help drive sales of PCT systems into many new customer sites and applications globally."
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=270569
(0)
(0)Scroll down for more posts ▼